Jilin Province Huinan Changlong Bio-pharmacy (8049.HK) Earnings Analysis
Jilin Province Huinan Changlong Bio-pharmacy (8049.HK) has no confirmed upcoming earnings date. Trailing P/E 5.58.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 8049.HK next report earnings?
No confirmed upcoming earnings date is currently scheduled for 8049.HK. This page updates as the calendar is published.
8049.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-08-14 | 0.1006 HKD | n/a | n/a | n/a |
| 2024-12-17 | 0.07596 HKD | n/a | n/a | n/a |
| 2024-11-29 | 0.07901 HKD | n/a | n/a | n/a |
| 2024-08-14 | 0.09998 HKD | n/a | n/a | n/a |
8049.HK valuation and analyst view
| Trailing P/E | 5.58 |
|---|---|
| Trailing EPS | 0.35499 HKD |
| Price / book | 0.66 |
| Dividend yield | 12.49% |
| Market cap | 1.31B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Jilin Province Huinan Changlong Bio-pharmacy (8049.HK)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 8049.HK. This page updates as the calendar is published.
Did 8049.HK beat earnings last quarter?
Consensus estimate data was not available for 8049.HK's 2025-08-14 report.
What is 8049.HK's current P/E ratio and EPS?
8049.HK trades at a trailing P/E of 5.58 on trailing EPS of 0.35499086837021815 HKD.
What do analysts rate 8049.HK?
8049.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.